Consortium to Establish a Registry for Alzheimer's Disease (CERAD).

The article offers information on the standardized instruments and assessments developed by the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) and funded by the National Institute on Aging in the U.S. The primary assessments developed by CERAD include a clinical battery, a neuropsychological battery and a neuropathological assessment.